Literature DB >> 31230554

Characterization and Gene Expression Analysis of Serum-Derived Extracellular Vesicles in Primary Aldosteronism.

Jacopo Burrello1, Chiara Gai2, Martina Tetti1, Tatiana Lopatina2, Maria Chiara Deregibus2, Franco Veglio1, Paolo Mulatero1, Giovanni Camussi2, Silvia Monticone1.   

Abstract

Patients affected by primary aldosteronism (PA) display an increased risk of cardiovascular events compared with essential hypertension (EH). Endothelial dysfunction favors initiation and progression of atherosclerosis and circulating extracellular vesicles (EVs), reflecting endothelial cell activity, could represent one of the mediators of endothelial dysfunction in these patients. The aim of this study was to characterize circulating EVs from patients diagnosed with PA and to explore their functional significance. Serum EVs were isolated from 12 patients with PA and 12 with EH, matched by sex, age, and blood pressure, and compared with 8 normotensive controls. At nanoparticle tracking analysis, EVs concentration was 2.2× higher in patients with PA ( P=0.033) compared with EH and a significant correlation between EV number and serum aldosterone and potassium levels was identified. Fluorescence-activated cell sorting analysis demonstrated that patients with PA presented a higher absolute number of endothelial-derived EVs compared with both patients with EH and normotensive controls. Through EV mRNA profiling, 15 up-regulated and 4 down-regulated genes in patients with PA compared with EH were identified; moreover, EDN1 was expressed only in patients with PA. Microarray platform was validated by quantative real-time polymerase chain reaction on 4 genes ( CASP1, EDN1, F2R, and HMOX1) involved in apoptosis, inflammation, and endothelial dysfunction. After unilateral adrenalectomy, EVs number and expression of CASP1 and EDN1 significantly decreased in patients with PA ( P<0.05). Additionally, the incubation with PA-derived EVs reduced angiogenesis and induced apoptosis in vitro. Circulating EVs might not only represent a marker of endothelial dysfunction but also contribute themselves to vascular dysfunction in patients with PA.

Entities:  

Keywords:  aldosterone; endothelin-1; endothelium; extracellular vesicles; hypertension

Mesh:

Substances:

Year:  2019        PMID: 31230554     DOI: 10.1161/HYPERTENSIONAHA.119.12944

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Knockout of the circadian clock protein PER1 results in sex-dependent alterations of ET-1 production in mice in response to a high-salt diet plus mineralocorticoid treatment.

Authors:  Lauren G Douma; G Ryan Crislip; Kit-Yan Cheng; Dominique Barral; Sarah Masten; Meaghan Holzworth; Emilio Roig; Krystal Glasford; Kevin Beguiristain; Wendy Li; Phillip Bratanatawira; I Jeanette Lynch; Brian D Cain; Charles S Wingo; Michelle L Gumz
Journal:  Can J Physiol Pharmacol       Date:  2020-09-11       Impact factor: 2.273

2.  uEVs: A Potential Tool for Examining Renal Epithelial Cells.

Authors:  Katherine S Deck; Shengyu Mu
Journal:  Kidney360       Date:  2022-04-26

Review 3.  Role of Extracellular Vesicles in the Pathogenesis of Vascular Damage.

Authors:  Fabrizio Buffolo; Silvia Monticone; Giovanni Camussi; Elena Aikawa
Journal:  Hypertension       Date:  2022-02-11       Impact factor: 9.897

Review 4.  Endothelial Dysfunction in Primary Aldosteronism.

Authors:  Zheng-Wei Chen; Cheng-Hsuan Tsai; Chien-Ting Pan; Chia-Hung Chou; Che-Wei Liao; Chi-Sheng Hung; Vin-Cent Wu; Yen-Hung Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

5.  Serum Alpha-1-Acid Glycoprotein-1 and Urinary Extracellular Vesicle miR-21-5p as Potential Biomarkers of Primary Aldosteronism.

Authors:  Cristian A Carvajal; Alejandra Tapia-Castillo; Jorge A Pérez; Carlos E Fardella
Journal:  Front Immunol       Date:  2021-11-05       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.